Associated Papers
Prognostic and functional role of PPAR-alpha and SNP receptor (Leu162Val) in acute coronary syndrome: a potential novel target.
Raeef AA et al.
Journal, Genetic Engineering & Biotechnology, 2025
Associations of the PPARα and Lipoprotein Lipase Enzyme Gene Polymorphisms with Dyslipidemia in Obese and Non-obese Males.
Al-Samawi RI et al.
Journal of Obesity & Metabolic Syndrome, 2024
PPARA and IL6: exploring associations with athletic performance and genotype polymorphism.
Kazancı D et al.
Cellular and Molecular Biology (noisy-le-grand, France), 2023
Does the PPARA Intron 7 Gene Variant (rs4253778) Influence Performance in Power/Strength-Oriented Athletes? A Case-Control Replication Study in Three Cohorts of European Gymnasts.
Maciejewska-Skrendo A et al.
Journal of Human Kinetics, 2021
Association of Elite Sports Status with Gene Variants of Peroxisome Proliferator Activated Receptors and Their Transcriptional Coactivator.
Petr M et al.
International Journal of Molecular Sciences, 2019
Impact of PPAR-Alpha Polymorphisms-The Case of Metabolic Disorders and Atherosclerosis.
Ruscica M et al.
International Journal of Molecular Sciences, 2019
Association of PPAR Alpha Intron 7 G/C, PPAR Gamma 2 Pro12Ala, and C161T Polymorphisms with Serum Fetuin-A Concentrations.
Márkus B et al.
Ppar Research, 2017
The association of peroxisome proliferator-activated receptor α with diabetic retinopathy, and additional gene-obesity interaction in Chinese type 2 diabetes mellitus patients.
Qi S et al.
Obesity Research & Clinical Practice, 2016
Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case-control study and meta-analysis.
Qian Y et al.
Medicine, 2016
Sports genetics: the PPARA gene and athletes' high ability in endurance sports. A systematic review and meta-analysis.
Lopez-Leon S et al.
Biology of Sport, 2016
Genetic score of power-speed and endurance track and field athletes.
Ben-Zaken S et al.
Scandinavian Journal of Medicine & Science in Sports, 2015
[Association between polymorphisms, haplotypes of peroxisome proliferators activated receptor a gene and the level of lipoprotein (a)].
Xie H et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi, 2014
Gene-Gene Interactions among Pparα/δ/γ Polymorphisms for Apolipoprotein (Apo) A-I/Apob Ratio in Chinese Han Population.
Hai B et al.
Iranian Journal of Public Health, 2014
The polygenic profile of Russian football players.
Egorova ES et al.
Journal of Sports Sciences, 2014
PPARA intron polymorphism associated with power performance in 30-s anaerobic Wingate Test.
Petr M et al.
Plos One, 2014
PPARα gene variants as predicted performance-enhancing polymorphisms in professional Italian soccer players.
Proia P et al.
Open Access Journal of Sports Medicine, 2014
Genes for elite power and sprint performance: ACTN3 leads the way.
Eynon N et al.
Sports Medicine (auckland, N.z.), 2013
The association of gene polymorphisms with athlete status in ukrainians.
Drozdovska SB et al.
Biology of Sport, 2013
Is PPARα intron 7 G/C polymorphism associated with muscle strength characteristics in nonathletic young men?
Broos S et al.
Scandinavian Journal of Medicine & Science in Sports, 2013
PPAR-α as a key nutritional and environmental sensor for metabolic adaptation.
Contreras AV et al.
Advances in Nutrition (bethesda, Md.), 2013
The association of ACE, ACTN3 and PPARA gene variants with strength phenotypes in middle school-age children.
Ahmetov II et al.
The Journal of Physiological Sciences : Jps, 2013
Genetic influences in sport and physical performance.
Puthucheary Z et al.
Sports Medicine (auckland, N.z.), 2011
Physiological variables and mitochondrial-related genotypes of an athlete who excels in both short and long-distance running.
Eynon N et al.
Mitochondrion, 2011
Genes and elite athletes: a roadmap for future research.
Eynon N et al.
The Journal of Physiology, 2011
Association of the peroxisome proliferator-activated receptor α gene L162V polymorphism with stage C heart failure.
Arias T et al.
Journal of Hypertension, 2011
PPARα polymorphisms as risk factors for dyslipidemia in a Brazilian population.
Mazzotti DR et al.
Molecular Genetics and Metabolism, 2011
Variation in the PPARα gene in Polish rowers.
Maciejewska A et al.
Journal of Science and Medicine in Sport, 2011
Association of PPARα Intron 7 Polymorphism with Coronary Artery Disease: A Cross-Sectional Study.
Purushothaman S et al.
Isrn Cardiology, 2011
PPAR transcriptional activator complex polymorphisms and the promise of individualized therapy for heart failure.
Mistry NF et al.
Heart Failure Reviews, 2010
Do PPARGC1A and PPARalpha polymorphisms influence sprint or endurance phenotypes?
Eynon N et al.
Scandinavian Journal of Medicine & Science in Sports, 2010
Association of PPARalpha gene polymorphisms and lipid serum levels in a Brazilian elderly population.
Chen ES et al.
Experimental and Molecular Pathology, 2010
ANGPTL4 E40K and T266M: effects on plasma triglyceride and HDL levels, postprandial responses, and CHD risk.
Talmud PJ et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2008
Single gene contributions: genetic variants of peroxisome proliferator-activated receptor (isoforms alpha, beta/delta and gamma) and mechanisms of dyslipidemias.
Yong EL et al.
Current Opinion in Lipidology, 2008
APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome.
Miller M et al.
Archives of Medical Research, 2007
[The association of gene polymorphisms with the muscle fiber type composition].
Akhmetov II et al.
Rossiiskii Fiziologicheskii Zhurnal Imeni I.m. Sechenova, 2006
PPARalpha gene variation and physical performance in Russian athletes.
Ahmetov II et al.
European Journal of Applied Physiology, 2006
Variation in the lipoprotein lipase gene influences exercise-induced left ventricular growth.
Flavell DM et al.
Journal of Molecular Medicine (berlin, Germany), 2006
Peroxisome proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetes.
Flavell DM et al.
Diabetes, 2005
Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes.
Foucher C et al.
Pharmacogenetics, 2004
APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study.
Talmud PJ et al.
Journal of Lipid Research, 2004
Peroxisome Proliferator-Activated Receptor α and γ Gene Polymorphisms among South Indian Patients with Diabetic Dyslipidaemia.
Bage IJ et al.
Indian Journal of Endocrinology and Metabolism, 0